BXP is the largest publicly traded developer, owner, and manager of premier workplaces in the United States. Organized as a real estate investment trust (REIT), the company focuses on Class A office properties concentrated in six gateway markets: Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, D.C. As of mid-2026, including properties owned through joint ventures, its portfolio totaled roughly 51.1 million square feet across 164 properties, spanning office, retail, residential, and one hotel asset.
Founded in 1970 and headquartered in Boston, BXP is known for its in-house building management expertise and its track record of developing premium central business district office buildings and mixed-use complexes for creditworthy tenants. Investors follow the stock for its exposure to institutional-quality urban office real estate, its life sciences portfolio, and its dependable dividend, which stood at an annualized rate of $2.80 per share. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the last 30 days, BXP advanced from an adjusted closing price of $59.37 in early October to roughly $65.95 by early November, a gain of approximately 11%. The move accelerated in the final sessions of the period, with the stock jumping more than 5% in a single session as investors reacted to third-quarter results.
The broader quarterly picture is more muted. BXP reached a 52-week high of $74.94 in late July before entering a multi-month pullback that took shares into the high-$50s by mid-October. The recent earnings-driven rebound has narrowed that decline, but the stock still trades below where it stood at the start of the trailing quarter.
The primary catalyst behind the 30-day advance was BXP's third-quarter 2026 earnings report. The company posted funds from operations of $1.89 per share, exceeding management's own guidance, while revenue also came in ahead of expectations. Morningstar noted that strong occupancy growth helped drive the FFO beat.
Management also lifted its full-year 2026 profit outlook, pointing to higher occupancy across the portfolio. That combination of a quarterly beat and improved forward guidance gave investors a clear, tangible reason to re-rate the shares, triggering the sharp post-earnings rally that accounts for much of the 30-day gain. From what I see, this earnings momentum is important because it directly addresses occupancy concerns that have weighed on the sector.
Over the trailing quarter, BXP's share price has been shaped less by a single catalyst and more by the broader environment for office real estate. After peaking near $75 in late July, the stock drifted lower through August, September, and October as investors weighed persistent questions about office demand, hybrid-work trends, and the path of interest rates, which directly influence REIT valuations and financing costs.
The pullback into the high-$50s in mid-October reflected those sector-level concerns. The recent earnings beat and improved occupancy outlook have since shifted sentiment, but the stock has only partially recovered the ground lost earlier in the quarter. I’m watching this closely as interest-rate developments unfold.
Looking ahead, the most important factors for BXP are occupancy and leasing momentum, which directly affect both revenue and the company's ability to sustain or raise its guidance. The direction of interest rates will also matter, given their influence on REIT valuations, borrowing costs, and property values.
Investors should monitor the next quarterly earnings report for updated FFO guidance and commentary on the return-to-office environment and life sciences demand. Sector-level indicators such as office utilization data and leasing volumes in BXP's gateway markets will provide additional context. Wall Street's consensus on BXP is a Moderate Buy, with average 12-month price targets in the low-to-mid $70s according to recent analyst data, though individual forecasts vary.
In my analysis of BXP, I turned to Tickeron’s AI Daily Buy/Sell Signals to cross-check momentum indicators against broader market patterns. This helped confirm the post-earnings shift without replacing my own fundamental review.
When reviewing automated strategies around real estate names like BXP, I often look at Tickeron’s Trending AI Robots to see how different models are positioned. The section highlights top-performing bots across various timeframes and approaches, which can offer useful data-driven signals to complement traditional research. In my view, checking these models provides another lens on how algorithmic trading is interpreting current conditions in the sector.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for BXP crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.
The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on BXP as a result. In 61 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.
The Moving Average Convergence Divergence (MACD) for BXP just turned positive on October 15, 2026. Looking at past instances where BXP's MACD turned positive, the stock continued to rise in 33 of 53 cases over the following month. The odds of a continued upward trend are 62%.
BXP moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where BXP advanced for three days, in 169 of 289 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BXP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
BXP broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BXP entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BXP's P/B Ratio (1.931) is slightly higher than the industry average of (0.873). P/E Ratio (33.565) is within average values for comparable stocks, (201.021). BXP's Projected Growth (PEG Ratio) (2.319) is very high in comparison to the industry average of (0.666). Dividend Yield (0.045) settles around the average of (0.163) among similar stocks. P/S Ratio (3.040) is also within normal values, averaging (2.856).
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating fairly steady price growth. BXP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 61 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BXP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a real estate investment trust
Industry REITOffice